Not only do these data support that the PD-L1 expression does not represent a perfect biomarker for ICIs response across all tumor settings, but also suggest that a non-canonical tumor PD-L1 expression (i.e., constitutive) might even associate with mechanisms of immune resistance. Here, CD274 is linked to neoplasm.